The global DNA & gene chip market size is expected to reach USD 10.7 billion by 2025, according to a new report by Grand View Research, Inc., at an 11.4% CAGR during the forecast period. DNA and gene chips have gained much success in providing high throughput capabilities for comprehensive genome studies to enhance disease knowledge and target them. This technology has emerged as a valuable and promising solution across various aspects of disease management. These factors have been driving the market.
Conventional means of gene analysis allow investigation of relatively small amounts of genes at a time, which further emphasizes on the uptake of DNA microarray technology. DNA microarray technology allows concurrent analysis of very large numbers of nucleic acid fragments in a single experiment.
For PDF sample Copy or More Details please visit link @: https://www.grandviewresearch.com/industry-analysis/dna-gene-chip-market
Continuous development of new tools to support and enhance the reliability of DNA microarray technology is likely to drive this market at a significant pace in the foreseeable future. Furthermore, healthcare entities are engaged in exploiting novel solutions for enhancing and combining data generated from gene chip with data generated from high throughput technologies. Mutually beneficial partnerships between microarray developers and pharmaceutical/biopharmaceutical companies for the acceleration of genomic and biomedical research activities is anticipated to spur market growth in the coming years.
DNA & Gene Chip Market Report Highlights
• Based on product, consumables dominated the market with the largest share. This is due to the presence of a large number of entities engaged in providing reagents and kits associated with the use of DNA chips
• The cancer treatment and diagnosis segment accounts for a significant share in the market owing to the rising inclination toward development of companion diagnostics and growing usage of DNA microarrays in cancer diagnosis and treatment
• Implementation of gene chip for drug discovery is also expected to increase in the coming years owing to the growing demand for personalized medicine
• By end use, academic/government research institutes accounted for the largest share in 2017. Ongoing research projects on gene expression analysis in these institutes have attributed to the estimated share
• In terms of region, North America dominated the market in terms of revenue. High penetration of major revenue-generating companies in the U.S. has contributed to its leading share
• Asia Pacific is projected to witness the fastest year-on-year growth owing to rising healthcare spending in developing economies and an increase in R&D investment
• Some of the prominent market participants are Agilent Technologies; Thermo Fisher Scientific, Incorporated (Affymetrix, Inc.); Illumina, Inc.; Macrogen Inc.; and Arrayit Corporation. These players are engaged in mutual partnerships with research communities and other diagnostic firms for the use of gene chips for targeting disease prognosis.
To request research report sample copy with TOC please visit @: https://www.grandviewresearch.com/industry-analysis/dna-gene-chip-market/request/rs1
DNA & Gene Chip Market Segmentation
Grand View Research has segmented the global DNA & gene chip market on the basis of application, product, end use, and region:
DNA & Gene Chip Application Outlook (Revenue, USD Million, 2014 - 2025)
• Cancer diagnosis and treatment
• Gene expression
• Genotyping
• Genomics
• Drug discovery
• Agricultural biotechnology
• Others
DNA & Gene Chip Product Outlook (Revenue, USD Million, 2014 - 2025)
• Consumables
• Instrumentation
DNA & Gene Chip End-use Outlook (Revenue, USD Million, 2014 - 2025)
• Academic & Government Research Institutes
• Hospitals & Diagnostics Centers
• Biotechnology & Pharmaceutical Companies
• Others
DNA & Gene Chip Regional Outlook (Revenue, USD Million, 2014 - 2025)
• North America
o The U.S.
o Canada
• Europe
o Germany
o The U.K.
• Asia Pacific
o Japan
o China
• Latin America
o Brazil
• Middle East & Africa
o South Africa
For Inquire before buying please visit @: https://www.grandviewresearch.com/inquiry/5413/ibb
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.